Paints who underwent medical procedures using an Olympus Duodenoscope are filing lawsuits after contracting the “superbug” bacterial infection. Used to examine and diagnose the small intestine, gallbladder and pancreatic duct the Olympus duodenoscopy also spread infections throughout the body. Olympus never adequately warned patients and doctors that their Duodenoscope could cause the superbug until the FDA recalled the device on January 15, 2016.
Device Type: Duodenoscope
Injury: Bacterial Infection.
Total Cases: 250
Settlement Amounts: EST – Unknown
Bellwether Trial Start Date: Unkown
See If You Qualify
What is a Olympus Duodenoscope?
In a procedure known as an endoscopic retrograde cholangiopancreatography (ERCP) a small tube-like medical device is inserted into the mouth and down into the stomach to examine the duodenum, gallbladder and pancreatic duct. This helps to diagnose and treat health problems in the liver, bile ducts, and pancreas. Doctors are then able to watch through a chip at the tip of the duodenoscope that transmits images to a TV screen, and can also be used insert catheters through the duodenoscope or to inject dies needed for X-rays and to perform biopsies.
When was Olympus Duodenoscope recalled?
On January 2016, Olympus finally decided to recall the TJF-Q180V Duodenoscope to fix the health epidemic issues surrounding the device. The FDA has reviewed and cleared the new design. In a Press release given in January 2016, the FDA explained that Olympus had “changed its design to reduce the potential for leakage of patient fluids and tissue into the closed elevator channel.”